Oculoglandular listeriosis
ICD-10 A32.81 is a billable code used to indicate a diagnosis of oculoglandular listeriosis.
Oculoglandular listeriosis is a rare form of listeriosis, a bacterial infection caused by Listeria monocytogenes, which primarily affects the eyes and associated lymphatic tissues. This condition typically arises when the bacteria enter the body through the conjunctiva, often due to direct contact with contaminated materials, such as unpasteurized dairy products or infected animal tissues. Clinically, patients may present with unilateral conjunctivitis, swelling of the preauricular lymph nodes, and purulent discharge from the affected eye. Systemic symptoms may also occur, including fever and malaise. Diagnosis is confirmed through culture of the organism from ocular secretions or lymph nodes. Treatment usually involves the use of antibiotics, with ampicillin being the first-line therapy. In immunocompromised patients, more aggressive treatment may be necessary. The prognosis is generally good with prompt treatment, but delays can lead to complications, including vision loss.
Detailed notes on ocular symptoms, examination findings, and treatment plans.
Patients presenting with conjunctivitis and lymphadenopathy.
Ensure that the link between ocular symptoms and listeriosis is clearly established.
Comprehensive patient history, including exposure risks and laboratory results.
Patients with systemic listeriosis presenting with ocular symptoms.
Document any immunocompromised status that may affect treatment.
Used for follow-up visits after initial diagnosis and treatment of oculoglandular listeriosis.
Document the patient's progress, any new symptoms, and treatment adherence.
Ophthalmology may require additional visual acuity assessments.
Common symptoms include unilateral conjunctivitis, swollen preauricular lymph nodes, and purulent discharge from the eye, often accompanied by systemic symptoms like fever.